279 related articles for article (PubMed ID: 22327331)
1. Spironolactone prevents alterations associated with cardiac hypertrophy produced by isoproterenol in rats: involvement of serum- and glucocorticoid-regulated kinase type 1.
Martín-Fernández B; de las Heras N; Miana M; Ballesteros S; Valero-Muñoz M; Vassallo D; Davel AP; Rossoni LV; Cachofeiro V; Lahera V
Exp Physiol; 2012 Jun; 97(6):710-8. PubMed ID: 22327331
[TBL] [Abstract][Full Text] [Related]
2. Structural, functional, and molecular alterations produced by aldosterone plus salt in rat heart: association with enhanced serum and glucocorticoid-regulated kinase-1 expression.
Martín-Fernández B; de las Heras N; Miana M; Ballesteros S; Delgado C; Song S; Hintze T; Cachofeiro V; Lahera V
J Cardiovasc Pharmacol; 2011 Jan; 57(1):114-21. PubMed ID: 20980916
[TBL] [Abstract][Full Text] [Related]
3. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and prevents oxidative stress in uremic rats.
Michea L; Villagrán A; Urzúa A; Kuntsmann S; Venegas P; Carrasco L; Gonzalez M; Marusic ET
Hypertension; 2008 Aug; 52(2):295-300. PubMed ID: 18591458
[TBL] [Abstract][Full Text] [Related]
4. Mineralocorticoid receptors mediate cardiac remodelling in morphine-dependent rats.
Mesripour A; Iyer A; Brown L
Basic Clin Pharmacol Toxicol; 2012 Aug; 111(2):75-80. PubMed ID: 22304485
[TBL] [Abstract][Full Text] [Related]
5. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
6. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
[TBL] [Abstract][Full Text] [Related]
7. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
[TBL] [Abstract][Full Text] [Related]
8. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
[TBL] [Abstract][Full Text] [Related]
9. Anabolic steroid associated to physical training induces deleterious cardiac effects.
Do Carmo EC; Fernandes T; Koike D; Da Silva ND; Mattos KC; Rosa KT; Barretti D; Melo SF; Wichi RB; Irigoyen MC; de Oliveira EM
Med Sci Sports Exerc; 2011 Oct; 43(10):1836-48. PubMed ID: 21407130
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of proanthocyanidins in the cardiac alterations induced by aldosterone in rat heart through mineralocorticoid receptor blockade.
Martín-Fernández B; de las Heras N; Valero-Muñoz M; Ballesteros S; Yao YZ; Stanton PG; Fuller PJ; Lahera V
PLoS One; 2014; 9(10):e111104. PubMed ID: 25353961
[TBL] [Abstract][Full Text] [Related]
11. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans.
Hosoya K; Minakuchi H; Wakino S; Fujimura K; Hasegawa K; Komatsu M; Yoshifuji A; Futatsugi K; Shinozuka K; Washida N; Kanda T; Tokuyama H; Hayashi K; Itoh H
Kidney Int; 2015 Apr; 87(4):749-60. PubMed ID: 25337775
[TBL] [Abstract][Full Text] [Related]
13. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
14. Relevance of SGK1 in structural, functional and molecular alterations produced by aldosterone in heart.
Martín-Fernández B; Valero Muñoz M; de las Heras N; Ballesteros S; Lahera V
Horm Mol Biol Clin Investig; 2014 May; 18(2):53-61. PubMed ID: 25390002
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone receptor blockade prevents the transition to cardiac pump dysfunction induced by beta-adrenoreceptor activation.
Veliotes DG; Woodiwiss AJ; Deftereos DA; Gray D; Osadchii O; Norton GR
Hypertension; 2005 May; 45(5):914-20. PubMed ID: 15837836
[TBL] [Abstract][Full Text] [Related]
16. AT1 and aldosterone receptors blockade prevents the chronic effect of nandrolone on the exercise-induced cardioprotection in perfused rat heart subjected to ischemia and reperfusion.
Marques-Neto SR; Ferraz EB; Rodrigues DC; Njaine B; Rondinelli E; Campos de Carvalho AC; Nascimento JH
Cardiovasc Drugs Ther; 2014 Apr; 28(2):125-35. PubMed ID: 24258356
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model.
Nishimura H; Ito Y; Mizuno M; Tanaka A; Morita Y; Maruyama S; Yuzawa Y; Matsuo S
Am J Physiol Renal Physiol; 2008 May; 294(5):F1084-93. PubMed ID: 18353870
[TBL] [Abstract][Full Text] [Related]
18. Spironolactone and captopril attenuates isoproterenol-induced cardiac remodelling in rats.
Gallego M; Espiña L; Vegas L; Echevarria E; Iriarte MM; Casis O
Pharmacol Res; 2001 Oct; 44(4):311-5. PubMed ID: 11592866
[TBL] [Abstract][Full Text] [Related]
19. Spironolactone Prevents Endothelial Nitric Oxide Synthase Uncoupling and Vascular Dysfunction Induced by β-Adrenergic Overstimulation: Role of Perivascular Adipose Tissue.
Victorio JA; Clerici SP; Palacios R; Alonso MJ; Vassallo DV; Jaffe IZ; Rossoni LV; Davel AP
Hypertension; 2016 Sep; 68(3):726-35. PubMed ID: 27432866
[TBL] [Abstract][Full Text] [Related]
20. Aldosterone induces elastin production in cardiac fibroblasts through activation of insulin-like growth factor-I receptors in a mineralocorticoid receptor-independent manner.
Bunda S; Liu P; Wang Y; Liu K; Hinek A
Am J Pathol; 2007 Sep; 171(3):809-19. PubMed ID: 17724138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]